Locations:
Search IconSearch

Ob/Gyn & Women’s Health

The better the tech the better the treatment
January 26, 2022/Ob/Gyn & Women’s Health

Study Examines Sexual and Pelvic Floor Health Following Cystectomy in Female Patients

Urologic oncology and female urology collaborate on prospective clinical trial

21-RHE-2528454-SLE-and-PregnancyPlanning-CQD_650x450
January 17, 2022/Ob/Gyn & Women’s Health

Case Report: Systemic Lupus Erythematosus and Pregnancy Planning

Before, during and after your patient's pregnancy

OB/GYN Residents Wellness

Wellness Efforts Are Needed by OB-GYN Residents, But One Solution Does Not Fit All

Workshop curriculum was valued by some, while others would have preferred time for themselves

Endometriosis

New Risk Model Can Help Guide Clinical Care for Endometrioid Endometrial Cancer

Research helps identify patients who might benefit from adjuvant therapies

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Diaphragmatic endometriosis

Considerations for Diaphragmatic Endometriosis Surgery

Tips and techniques to help optimize resection and ablation of lesions in the diaphragm

Goje, MD
January 5, 2022/COVID-19

‘Most Unvaccinated People Are Not Anti-Vaxxers’

Ob/Gyn explains how she helps patients overcome COVID-19 vaccine hesitancy

21-DDI-2269958-Cass Intrapericardial CQD1_650x450 Hero
December 22, 2021/Digestive/Surgery

Cleveland Clinic Fetal Surgeons Resect Rare Intrapericardial Teratoma

Continued pregnancy and delivery are only the second successful outcome worldwide

Fetal surgeons
December 22, 2021/Digestive/Surgery

Fetal Surgery Program Plans to Offer New Capabilities

FETO and twin-twin transfusion syndrome treatments are next

Vaginitis diagnosis

The Art and Science of Diagnosing Vaginitis

Proper diagnosis and treatment require a careful mix of patient and clinical considerations

Ovarian tumor

PARP Inhibitors Decrease Response to Subsequent Platinum-Based Chemotherapy in Recurrent Ovarian Cancer

Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer

BackPage 11 of 37Next

Advertisement

Ad